chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild arm soreness; This is a spontaneous report from a contactable pharmacist and a contactable physician (patient). A 33-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EH9899) via intramuscularly on 26Dec2020 at 10:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had no significant preexisting medical conditions prior to the vaccine. Concomitant medications were not reported. It was unknown, whether the patient was diagnosed with COVID-19 prior to vaccination and it was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date, after the first dose the patient experienced mild arm soreness. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Pt called and stated that MD said that she has the shingles due to vaccine. Rash on neck and face and forehead on left side.
Right deltoid swollen, red, warm to touch (61/2 cm x 7 1/2 cm).  Reminded father to apply ice pack Q2 hrs for 15 min.  Then warm compress @ 24 hrs.  If redness swelling increase to comeback.
Swollen gland near left ear causing discomfort. This happened with other doses as well.
Initial unsolicited report received from a Nurse on 23 January 2017. This case involves a 24-year-old female patient who was vaccinated with a first dose of ADACEL (batch number: U5521BA, expiry date: 10 December 2018, dose and dose in series were not reported) in left deltoid on 17 January 2016. Patient's medical history as pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) and Illness at the time of vaccination were reported as none. Concomitant medications were not reported. Any other vaccinations within four weeks of vaccinations were reported as none. On 22 January 2016, 5 days of following the vaccination, the patient's left arm was bruised and had a large red area of 4.5 inches long and about 3 inches wide with bruising at the injection site. The patient required emergency room (ER)/ doctor visit. Laboratory investigations was reported as none. The patient had received CLARITIN and BENADRYL and apply cool compresses as a corrective treatment. The outcome of the events were reported as not recovered. List of documents held by sender: none.
Periods of dizziness for 4 hours followed by patient unable to stand, almost passed out, lasted most of day and for two days after feeling of not being connected to surroundings
This initial spontaneous report was received on 20-NOV-2017 from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. The patient was inoculated with ZOSTAVAX on or about 13-OCT-2006, administered (by an unspecified person) at a medical center, as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 27-MAY-2014, the patient was treated by a physician at the same medical center (where she received the vaccination) for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. On or about the dates of 06-JUN-2014, 09-JUN-2014, 16-JUN-2014, and 27-JUN-2014 the patient sought subsequent medical treatment at the same medical center for ongoing and worsening symptoms and pain attributable to uncontrolled zoster outbreaks.  The female was further diagnosed with post-herpetic neuralgia, a chronic condition of nerve damage and pain secondary to zoster infections. On or about 01-JUL-2014, the patient was treated by the physician/MD for uncontrolled symptoms of zoster. On or about 16-SEP-2014, the patient was treated by the same physician/MD again who observed that the patient's ongoing post-herpetic neuralgia had been persistent for more than three (as reported) duration. On or about the dates of 24-SEP-2014, 25-SEP-2014, 02-OCT-2014 and 13-OCT-2014, the patient underwent continued treatment of extreme pain and secondary complications of post herpetic neuralgia and shingles. The patient was referred to specialist neurologists and pain management physicians to attempt to curb these symptoms. On or about 12-JUL-2017, the female patient was treated by a physician/MD at a pain management center for special therapies to help manage her prolonged and agonizing condition. The patient has been prescribed valacyclovir (VALTREX), prednisone, topical steroid cream, gabapentin, acetaminophen, hydrocodone bitartrate (NORCO), oxycodone, acetaminophen, oxycodone hydrochloride (PERCOCET), onabotulinumtoxinA (BOTOX) therapy and neuromodulation treatment in attempts to manage her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not resolved. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
Pt developed very significant right shoulder pain.  After persistent pain an MRI was ordered and a rotation cuff tear was noted.  Pt underwent repair by orthopedics 05/06/03.  Doing well at physical 12/17/03.
Pt came in for Meningoccal vaccine on 8-4-08 @ 10:50am.  Denied having neurological s+s after any previous vaccine and denied ever having GBS.  On written consent denied allergies to latex too.  Pt called and came in on 8/6/08 stating,"I've had a terrible headache with nausea and blurred vision."  Pt evaluated by Dr and was referred to the ER for evaluation.  On 8-7-08 Pt was called and he stated,"CT Scan negative and blood work did not show any infection. Refused spinal tap."  Had no further blurred vision or nausea  but continues with headache.  On 8-8-08 spoke with patient and states, "I'm feeling better."
vaccine administered on 4/26/2022, beyond use date was 04/18/2022 exp date was 5/31/2022
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (little reaction) and fatigue (felt tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 029A21A and 012M20A) for COVID-19 immunization. No medical history reported. On Feb 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 9, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 9, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced vaccination complication (little reaction). On Mar 10, 2021, patient experienced fatigue (felt tired). In March 2021, vaccination complication (little reaction) and fatigue (felt tired) resolved. No concomitant medication or treatment information provided. This case linked to MOD-2021-378309, MOD-2021-378335 (patient link).
pt recv vax 31JUL95 & 11MAY97 pt exp chicken pox w/50 to 60 lesions;
Cannot get out of bed; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Cannot get out of bed), HEADACHE (Headache) and PYREXIA (Fever) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No reported medical history.     On 15-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced MOBILITY DECREASED (Cannot get out of bed), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, MOBILITY DECREASED (Cannot get out of bed), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.            Concomitant product use was not provided. There were no treatment medications. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   This case was linked to MOD-2021-132680 (Patient Link).
Patient had a vasovagal response and passed out about a minute after the actual injection of the vaccine.  He was unresponsive, was twitching, urinated himself, and when he woke up was slightly confused.
his left arm entire bicep there's giant hematoma, a bruised yellowish green blue; his left arm entire bicep there's giant hematoma, a bruised yellowish green blue; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported for himself. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in left arm on 18Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient said that in his left arm entire bicep there's giant hematoma, a bruised yellowish green blue in Jan2021. It was around 2 inches wide by 5 inches long and didn't know if it was from the COVID-19 Vaccine since he didn't do anything last week after taking the vaccine. The outcome of events was unknown.   Information about lot/batch number has been requested.
Started to be awakened at night with numbness is different parts of my body.  Sometimes sharp pains and sometime tingling.  I have never experienced anything like that before and just waited for several months thinking it would go away.  I went to my doctor and he suggested it was carpel tunnel and then saw my pain management doctor and he suggested the same thing.  I had the test and it was determined that it was not carpel tunnel.  My Primary doctor then did blood work and the work came back with a marker.  I was then sent to see Dr. She started me on Methotrexate and folic acid.   After about 6 months, at the third visit Dr. told me I have Rheumatoid Arthritis.
Discharge Provider: MD Primary Care Provider: PA Admission Date: 9/16/2022 Discharge Date: Sep 26, 2022  PRESENTING PROBLEM: Scapholunate ligament injury with no instability, left, initial encounter [S69.92XA] Closed compression fracture of L2 lumbar vertebra, initial encounter [S32.020A] Closed compression fracture of body of L1 vertebra [S32.010A] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 71F with history of diabetes mellitus type 2 hypertension, GERD, fibromyalgia, hyperlipidemia, depression, multiple back surgeries presented to the ER after a fall and back pain.  Patient reported suffer a mechanical fall causing low back pain and left wrist pain.  In the ER, CT head and cervical spine were negative for acute fractures.  CT abdomen/pelvis/lumbar spine showed CT revealed likely acute mild L2 compression fracture, new but age indeterminate L1 vertebral compression deformity and nodular liver.  Xray of L hand showed DJD of thumb, possible scapholunate ligament injury. No acute fracturePatient incidentally tested positive for COVID-19 without having respiratory symptoms.  She was admitted for further workup.   Neurosurgery was consulted for concerns of compression fracture. Hand surgery was consulted for possible L scapholunate ligament injury.  Them accommodation from Hand surgery was to place a velcro splint and extremity elevated with ice as needed.  Non weight-bearing left upper extremity in place and conservative management and no surgical intervention at this time.   Intervention Radiology planning vertebroplasty on 09/20/2022.
Headache, NauseaVomiting, swollen axillary lymph nodes, photophobia Narrative:
Headache, chills, nausea, vomiting, aches and pain, severe pain in kidneys, eye pain, weakness, loss of appetite,
Information has been received from a Nurse concerning a 16 year old female who on 16-FEB-2007 was vaccinated IM in the left deltoid with a 0.5 ml first dose of Gardasil (lot# 653735/0688F).  On 26-APR-2007 the patient received IM in the left gluteal muscle with a second dose (lot# 657006/0188U) and on 21-Aug-2007 received IM in the unspecified gluteal muscle with the third dose (lot# 657622/0388U).  The nurse mentioned that the patient experienced pain after receiving the first dose.  Medical attention was sought.  Subsequently the patient recovered from pain.  No product quality complaint was involved.  The nurse mentioned almost every patient (unspecified number) who received the vaccine complained of having pain for 2 or 3 days.  Attempts are being done to find more information about other patients.  Additional information has been requested. Information has been received from a nurse concerning a 16 year old female who on 16-FEB-2007 was vaccinated IM in the left deltoid with 0.5 ml first dose of HPV vaccine (lot # 653735/0688F). On 26-FEB-2007 the patient received IM in the left gluteal muscle with a second dose (lot # 657006/0188U) and on 21-AUG-2007 received IM in the unspecified gluteal muscle with the third dose (lot # 657522/0388U). The nurse mentioned that the patient experienced pain after receiving the first dose. Medical attention was sought. Subsequently the patient recovered from pain. No product quality complaint was involved. The nurse mentioned alsmost every patient (unspeciifed number) who received the vaccine complained of having pain for 2 or 3 days. Attempts are being done to find more information about the other patients. Follow-up information from the nurse indicated that there were approximately 300 patients who received the vaccination. She was not able to provide specific patient identifiers. Additional information has been requested.
3/13/2012: Patient presented to clinic. States she received dtap & pneumococcal 3/12/12 approx 1530. At 2230 broke out in generalized hives. Patient has strong hx of urticaria. Sees allergist for this. Took BENADRYL & hives went away. Needed lab work but lab would not do until cleared by provider. Uncertain if immunizations reaction. Same pt has history of urticaria.
8-14-09 - 8-19-09 pt c/o eye lids being swollen. 8-15-09 - 8-19-09 pt c/o tension like headache. Pt took TYLENOL and BENADRYL. Talked to pt on 8/25/09 and she stated symptoms had subsided.
Patient received Td injection and next day developed redness, swelling at injection site, generalized muscle pain, muscle tightness, nausea and chills. Patient visited Urgent Care Center to report an adverse event. At the time of the visit patient's reaction was subsiding. Patient still had some generalized muscle pain and was given Benadryl and Ibuprofen.
Caller stated that  about 4:00 in the morning 11/17/20  she had chills and fatigue lasting about 8 hours.
This patient had hives on his face 20 minutes after vaccinations. He was given Benadryl, the hives resolved by 45 minutes after the vaccinations. His right tricep area also slightly swollen and tender.
Rash-began on right arm and behind R ear. Awoke at 00:40 with itching. Over course of morning, noted rash spreading up arm, down R hip and leg and L wrist/forearm. Took BENADRYL and applied cortisone cream with little relief.
Patient received vaccine off site - the vaccine was transported in a certified vaccine pack out cooler  with a data logger at refrigerated temperature (2 to 8 C). A temperature excursion occurred while vaccine was off site between 1052 to 1222 with temperature between 1.6 C and 2.0 C. It was unclear the exact time the patient received the vaccine but the vaccinator estimated that patient received vaccine between 1100 and 1135. Patient received the 2nd dose of vaccine dose of vaccine drawn from the vial and the vial was opened only a few minutes prior to that. Contacted manufacturer for guidance the have excursion data for an unopened vial stored at 0 to 1 C which states 'no restriction in duration provided the product is not expired'. Since the vial had been opened briefly before the dose was drawn for this patient we discussed the situation with our overseeing physician and recommendation was to notify patient of excursion and let patient decide if he would like to be revaccinated. Notified patient of the situation the next day via Spanish translator (he is Spanish speaking) and also asked if we could remember the time he received the vaccine and he thought it was just before 1100. Patient decided not to be revaccinated at this time.
Rash chills chest pain headache fever body pain shortness of breath fast beating weakness armpits swollen
Post vax, the pt had a small rash with itching. She took Benadryl over the weekend. As of 4/3/00, she still had itching.
Rash; Breathing problems; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number was not reported, Expiry date: Unknown) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced rash, breathing problems. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a physician via call center representative and described the occurrence of thrombocytopenia in a patient who received SHINGRIX (batch number H547E, expiry date unknown) for prophylaxis. On 14th September 2018, the patient received SHINGRIX. In September 2018, less than a month after receiving SHINGRIX, the patient experienced thrombocytopenia (serious criteria hospitalization and GSK medically significant) and hemorrhage (serious criteria GSK medically significant). On an unknown date, the outcome of the thrombocytopenia and hemorrhage were unknown. It was unknown if the reporter considered the thrombocytopenia and hemorrhage to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported, but was captured as adult as per the vaccine indication. The healthcare professional (HCP) reported that the patient received SHINGRIX on and developed severe thrombocytopenia. The patient were admitted to the hospital with bleeding and a platelet count of 8,000. In August, their platelet count was normal and this vaccine is the only thing that could have caused it because they had been on all their other medications prior as per the doctor. This information was left on the adverse event voicemail box. The voice mail escalated Vaccine MES to followup with the doctor. The doctor wanted to know if this reaction was reported with SHINGRIX because she was not sure if this occurred due to the vaccine.
ED to hospital admission within 6 weeks of receiving COVID vaccination. Currently hospitalized as of 8/17.
Headache, Myalgia, Fever, Pain at the injection site and fatigue Narrative:
High fever, 104 degrees +. Didn't go under 101 degrees even with Tylenol and/or Motrin for three days. Fever finally broke after almost 18 hours straight sleep on 11/24/13. Bumpy rash appeared morning of 11/25/13. Baby is fussy, lack of appetite.
Client (DOB:09/26/1965) received the 2nd dose of Pfizer COVID vaccine lot # EW0179 and expiration date 5/10/21 at 2:25pm.  Client reports to EMT that he feels nausea and sat down at 2:10pm.  PHN arrived to assist and found client sitting upright alert and oriented x 4.  Client reports to PHN that he has a bubbling feeling in his stomach "like the feeling you get before you throw up". Client reports that since he stopped exercising and  has not been feeling as good and has an appointment with primary and lab work later today. Vitals at 2:25pm blood pressure: 138/94, oxygen: 96% and pulse 58. Client denies, headache and chest pain and shortness of breath.  Vitals at 2:30pm blood pressure: 145/94, oxygen: 97%, and pulse: 62.  At 2:42pm blood pressure: 140/90, oxygen: 98% and pulse:69, Client reports nausea is slightly improved and that "bubbling" feels better.  At 2:52pm vitals are blood pressure:140/85, oxygen: 97%, and pulse:66.  Client reports nausea is slightly improved and that "bubbling" feels better. At 2:56pm vitals are blood pressure: 138/90, oxygen:97%,  and pulse:53. Client reports feeling better and that nausea and stomach pain have resolved.  Client left facility unassisted with a steady gait at 2:59pm.
Swollen lips. Bumps on lips. Tingling lips. Treatment was a shot of allergy medication.
pt started crying nonstop approx 1 hr p/given vax; cried for 3 hr rt leg was swollen bad according to mother; mother gave pt APAP as directed; next day mom denied fever;
Was quesy & light headed those 2 days.; FATIGUE; That night I had chills all night; I had a really bad headache; Was quesy & light headed those 2 days.; Very tired & achey also those 2 days.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Was quesy & light headed those 2 days.), FATIGUE (FATIGUE), CHILLS (That night I had chills all night), HEADACHE (I had a really bad headache) and NAUSEA (Was quesy & light headed those 2 days.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Was quesy & light headed those 2 days.), FATIGUE (FATIGUE), CHILLS (That night I had chills all night), HEADACHE (I had a really bad headache), NAUSEA (Was quesy & light headed those 2 days.) and MYALGIA (Very tired & achey also those 2 days.). At the time of the report, DIZZINESS (Was quesy & light headed those 2 days.), FATIGUE (FATIGUE), CHILLS (That night I had chills all night), HEADACHE (I had a really bad headache), NAUSEA (Was quesy & light headed those 2 days.) and MYALGIA (Very tired & achey also those 2 days.) outcome was unknown.            No concomitant and treatment medications were reported.
left face, cheek and ear with sensation change. lasted few days. headache, arm pain, body ache for days
sore injection site arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore injection site arm). On 05-Feb-2021, VACCINATION SITE PAIN (sore injection site arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter   This case was linked to MOD-2021-238979 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Non-significant follow up appended - Email address updated.